The traditional drug discovery model, which is meant to treat rare diseases takes over a decade and consumes a huge investment. This is where the advancement of technology comes to play and makes it beneficial for patients by coming up with faster, more cost-effective and more efficient treatments.
One such company is Healx, which was founded in 2014 by Dr. Tim Guilliams and Dr. David Brown. The company uses Artificial Intelligence and patient-inspired technology, which makes it specialise in treatments for rare diseases.